Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zacest

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Drugs|January 1, 1974
beta-adrenoreceptor blocking drugs in hypertensionR Zacest
The Medical Journal of Australia|January 4, 1975
The clinical pharmacology of hypotensive vasodilator drugsR Zacest
Australian and New Zealand Journal of Medicine|August 1, 1976
The vasodilator--beta-blocker interaction--some determinants of its clinical successR Zacest
Clinical Pharmacology and Therapeutics|May 1, 1972
Relation of hydralazine plasma concentration to dosage and hypotensive actionR Zacest, J Koch-Weser
The Medical Journal of Australia|April 22, 1978
Hydrallazine and prazosinR Zacest, C L Wilson
Pharmacology|January 1, 1972
Relation of propranolol plasma level to beta-blockade during oral therapyR Zacest, J Koch-Weser
Lancet (London, England)|May 28, 1983
Endralazine and sexual arousalR Zacest, P A Reece
The Medical Journal of Australia|June 12, 1982
Intravenous administration of hydrallazineR Zacest, P A Reece
Clinical Pharmacology and Therapeutics|December 1, 1980
Kinetics of hydralazine and its main metabolites in slow and fast acetylatorsP A Reece, I Cozamanis, R Zacest
The Australian Journal of Experimental Biology and Medical Science|August 1, 1974
studies of plasma bradykininases using radiolabelled substratesR Zacest, S Oparil, R C Talamo
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Drugs|January 1, 1974
beta-adrenoreceptor blocking drugs in hypertensionR Zacest
The Medical Journal of Australia|January 4, 1975
The clinical pharmacology of hypotensive vasodilator drugsR Zacest
Australian and New Zealand Journal of Medicine|August 1, 1976
The vasodilator--beta-blocker interaction--some determinants of its clinical successR Zacest
Clinical Pharmacology and Therapeutics|May 1, 1972
Relation of hydralazine plasma concentration to dosage and hypotensive actionR Zacest, J Koch-Weser
The Medical Journal of Australia|April 22, 1978
Hydrallazine and prazosinR Zacest, C L Wilson
Pharmacology|January 1, 1972
Relation of propranolol plasma level to beta-blockade during oral therapyR Zacest, J Koch-Weser
Lancet (London, England)|May 28, 1983
Endralazine and sexual arousalR Zacest, P A Reece
The Medical Journal of Australia|June 12, 1982
Intravenous administration of hydrallazineR Zacest, P A Reece
Clinical Pharmacology and Therapeutics|December 1, 1980
Kinetics of hydralazine and its main metabolites in slow and fast acetylatorsP A Reece, I Cozamanis, R Zacest
The Australian Journal of Experimental Biology and Medical Science|August 1, 1974
studies of plasma bradykininases using radiolabelled substratesR Zacest, S Oparil, R C Talamo
Pageof 3